SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808805-24-000050
Filing Date
2024-06-17
Accepted
2024-06-17 17:37:24
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718660238.html 4  
1 FORM 4 wk-form4_1718660238.xml 4 4132
  Complete submission text file 0001808805-24-000050.txt   5699
Mailing Address C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Epperly Melissa B, (Reporting) CIK: 0001807359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 241049460

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)